CIK 0001528115
- Non-accelerated filer
- Smaller reporting company
Annexon, Inc.
Sign in to watch- Ticker
- ANNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 275414423
- Phone
- +1 650-822-5500
- Business address
- 1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
- 4 Open-market sale EVP & CHIEF INNOVATION OFFICER sold 1,810 shares at $5.54 ($10,027)
- 4/A Planned sale EVP & Chief Innovation Officer sold 22,057 shares at an average $4.49 ($99,021)
- 4 Open-market sale EVP & Chief Business Officer sold 978 shares at $3.84 ($3,752)
- 4 Open-market sale EVP & Chief Financial Officer sold 1,057 shares at $3.84 ($4,055)
- 4 Planned sale EVP & Chief Innovation Officer sold 21,000 shares at $4.52 ($94,966)
- 4 Open-market buy Director bought 350,000 shares at $2.88 ($1,008,000)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 300,000 shares at $2.13 ($639,720)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Grant or award EVP & Chief Business Officer acquired 18,975 shares (grant or award)
- 4 Grant or award EVP & Chief Financial Officer acquired 18,975 shares (grant or award)
Page 6 of 11 · 206 filings